Know Cancer

or
forgot password
  • cancer clinical trials in sacramento, CA

  • MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS)
    Novartis Investigative Site
    Sacramento, California 95817
    Pigmented Villonodular Synovitis, PVNS
    Tivantinib and Topotecan Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors or Recurrent Small Cell Lung Cancer
    UC Davis Comprehensive Cancer Center
    Sacramento, California 95817
    Recurrent Small Cell Lung Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
    Kaiser Permanente

    Trial Locations
    Kaiser Permanente
    UC Davis Comprehensive Cancer Center
    Kaiser Permanente-South Sacramento
    Kaiser Permanente - Sacramento
    Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    Bortezomib in Patients With Chronic Graft Versus Host Disease
    University of California Comprehensive Cancer Center
    Sacramento, California 95817
    Graft Versus Host Disease
    Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal Cancer
    University of California Comprehensive Cancer Center
    Sacramento, California 95817
    Non-Small Cell Lung Cancer, Colorectal Cancer
    Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis
    Northern California Research
    Sacramento, California 95821
    Actinic Keratosis
    Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed By Surgery
    UC Davis Comprehensive Cancer Center
    Sacramento, California 95817
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage III Salivary Gland Cancer, Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage III Verrucous Carcinoma of the Larynx, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IVA Salivary Gland Cancer, Stage IVA Squamous Cell Carcinoma of the Larynx, Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVA Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVA Verrucous Carcinoma of the Larynx, Stage IVA Verrucous Carcinoma of the Oral Cavity, Stage IVB Salivary Gland Cancer, Stage IVB Squamous Cell Carcinoma of the Larynx, Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVB Squamous Cell Carcinoma of the Oropharynx, Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVB Verrucous Carcinoma of the Larynx, Stage IVB Verrucous Carcinoma of the Oral Cavity, Stage IVC Salivary Gland Cancer, Stage IVC Squamous Cell Carcinoma of the Larynx, Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVC Squamous Cell Carcinoma of the Oropharynx, Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVC Verrucous Carcinoma of the Larynx, Stage IVC Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Chemoradiation Therapy and Ipilimumab in Treating Patients With Locally Advanced Cervical Cancer
    UC Davis Comprehensive Cancer Center
    Sacramento, California 95817
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage IIIB Cervical Cancer, Stage IVA Cervical Cancer
    TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer.
    Radiological Associates - Sacramento
    Sacramento, California 95816
    Non-HPV Locally Advanced Head and Neck Cancer
    Induction Chemotherapy Followed by Chemoradiotherapy for Head and Neck Cancer
    University of California Comprehensive Cancer Center
    Sacramento, California 95817
    Head and Neck Cancer
    Ofatumumab and Fresh Frozen Plasma in Patients With Chronic Lymphocytic Lymphoma
    University of California Comprehensive Cancer Center
    Sacramento, California 95817
    Chronic Lymphocytic Leukemia
    Bevacizumab With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Kidney Cancer
    UC Davis Comprehensive Cancer Center
    Sacramento, California 95817
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer, Type 1 Papillary Renal Cell Carcinoma, Type 2 Papillary Renal Cell Carcinoma
    Ipilimumab and Rituximab In Treating Patients With Relapsed or Refractory B-Cell Lymphoma
    UC Davis Comprehensive Cancer Center
    Sacramento, California 95817
    B-cell Chronic Lymphocytic Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Small Lymphocytic Lymphoma, Refractory Hairy Cell Leukemia, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Testicular Lymphoma, Waldenström Macroglobulinemia
    Bortezomib and Doxil for the Treatment of Patients With Acute Myelogenous Leukemia
    University of California Comprehensive Cancer Center
    Sacramento, California 95817
    Acute Myelogenous Leukemia
    A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® Gel 3% in the Treatment of Actinic Keratosis
    Northern California Research
    Sacramento, California 95821
    Actinic Keratosis
    Eversion in Dermatologic Surgery: Is Cosmetic Appearance Improved?
    UC Davis, Department of Dermatology
    Sacramento, California 95816
    Basal Cell Carcinoma, Squamous Cell Carcinoma, Melanoma
    Set-back Suture Versus Traditional Vertical Mattress Suture
    UC Davis, Department of Dermatology
    Sacramento, California 95816
    Basal Cell Carcinoma, Squamous Cell Carcinoma, Melanoma
    Randomized Controlled Trial Comparing Water vs. Air Method for Performing Colonoscopy in Adult Female Subjects
    University of California, Davis
    Sacramento, California 95818
    Screening for Colon Cancer
    S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer
    UC Davis Comprehensive Cancer Center
    Sacramento, California 95817
    Prostate Cancer
    Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma
    UC Davis Comprehensive Cancer Center
    Sacramento, California 95817
    Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma
    The Use of Microneedles in Photodynamic Therapy
    UC Davis, Dermatology
    Sacramento, California 95864
    Actinic Keratosis
    CTP Imaging of Lung Cancer
    University of California, Davis Medical Center
    Sacramento, California
    Non Small Cell Lung Cancer
    Phase 3 Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy
    UC Davis Medical Center
    Sacramento, California 95817
    Muscular Dystrophy, Duchenne, Muscular Dystrophies, Muscular Disorders, Atrophic, Muscular Diseases, Musculoskeletal Diseases, Neuromuscular Diseases, Nervous System Diseases, Genetic Diseases, X-Linked, Genetic Diseases, Inborn
    Breast Cancer Biomarker Sample Collection for the dtectDx Assay Verification
    Sutter Institute
    Sacramento, California 95816
    Breast Cancer
    Computed Tomography Versus Standard 2D Mammography Versus 3D Tomosynthesis
    UC Davis Medical Center
    Sacramento, California 95817
    Breast Cancer
    Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma
    UC Davis Comprehensive Cancer Center
    Sacramento, California 95817
    Epithelial Mesothelioma, Recurrent Malignant Mesothelioma, Sarcomatous Mesothelioma, Stage II Malignant Mesothelioma, Stage III Malignant Mesothelioma, Stage IV Malignant Mesothelioma
    Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer
    UC Davis Comprehensive Cancer Center
    Sacramento, California 95817
    Recurrent Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Community-Based Hepatitis B Interventions for Hmong Adults
    UC Davis Cancer Center
    Sacramento, California 95817
    Liver Cancer
    A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia
    UCD Med Ctr
    Sacramento, California 95817
    Anorexia, Cachexia, HIV Infections
    Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer
    University of California Davis Medical Center
    Sacramento, California 95817
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Leukemia, Liver Cancer, Lymphoma, Neuroblastoma, Ovarian Cancer, Psychosocial Effects of Cancer and Its Treatment, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme
    Radiation Oncology Center - Sacramento
    Sacramento, California 95816
    Brain and Central Nervous System Tumors
    Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma
    University of California Davis Medical Center
    Sacramento, California 95817
    Brain and Central Nervous System Tumors
    SWOG-9320 Combination Chemotherapy, Radiation Therapy, and Antiviral Therapy in Treating Patients With AIDS-Related Lymphoma
    University of California Davis Medical Center
    Sacramento, California 95817
    Lymphoma
    Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer
    Radiation Oncology Center - Sacramento
    Sacramento, California 95816
    Lung Cancer
    Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors
    Sutter Cancer Center

    Trial Locations
    Sutter Cancer Center
    University of California Davis Cancer Center
    Brain and Central Nervous System Tumors
    Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
    Radiation Oncology Center - Sacramento
    Sacramento, California 95816
    Prostate Cancer
    Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors
    University of California Davis Medical Center

    Trial Locations
    University of California Davis Medical Center
    Sutter Cancer Center
    Kidney Cancer
    Talc in Treating Patients With Malignant Pleural Effusion
    Radiation Oncology Center - Sacramento
    Sacramento, California 95816
    Metastatic Cancer
    Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer
    University of California Davis Medical Center
    Sacramento, California 95817
    Breast Cancer
    SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant
    University of California Davis Medical Center
    Sacramento, California 95817
    Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm
    SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia
    University of California Davis Medical Center
    Sacramento, California 95817
    Leukemia, Neutropenia, Thrombocytopenia
    Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia
    University of California Davis Medical Center
    Sacramento, California 95817
    Leukemia
    Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases
    Radiation Oncology Center - Sacramento
    Sacramento, California 95816
    Metastatic Cancer
    Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
    Sutter Cancer Center

    Trial Locations
    Sutter Cancer Center
    Kaiser Permanente Medical Center - Oakland
    Leukemia
    Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer
    Radiation Oncology Center - Sacramento
    Sacramento, California 95816
    Breast Cancer
    Combination Chemotherapy in Treating Patients With Advanced Head and Neck Cancer
    University of California Davis Medical Center
    Sacramento, California 95817
    Head and Neck Cancer
    SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial
    University of California Davis Cancer Center
    Sacramento, California 95817
    Breast Cancer, Cardiac Toxicity
    Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function
    University of California Davis Cancer Center
    Sacramento, California 95817
    Breast Cancer, Head and Neck Cancer, Lung Cancer, Ovarian Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    S9630, Medroxyprogesterone in Treating Women With Breast Cancer
    University of California Davis Cancer Center
    Sacramento, California 95817
    Breast Cancer, Endometrial Cancer
    S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery
    University of California Davis Medical Center
    Sacramento, California 95817
    Adrenocortical Carcinoma
    Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer
    University of California Davis Cancer Center
    Sacramento, California 95817
    Breast Cancer
    Combination Chemotherapy in Treating Children With Progressive Brain Tumors
    Sutter Cancer Center

    Trial Locations
    Sutter Cancer Center
    University of California Davis Cancer Center
    Kaiser Permanente Medical Center - Oakland
    Brain and Central Nervous System Tumors
    Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer
    University of California Davis Medical Center
    Sacramento, California 95817
    Endometrial Cancer
    Decitabine in Treating Patients With Melanoma or Other Advanced Cancer
    University of California Davis Cancer Center
    Sacramento, California 95817
    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific